Gurugram, India

Anil Shamraj Bhoyar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anil Shamraj Bhoyar. Retrieved from https://idiyas.com/inventor/anil-shamraj-bhoyar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anil Shamraj Bhoyar: Innovator in Pharmaceutical Chemistry

Introduction

Anil Shamraj Bhoyar is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. His work is characterized by a commitment to improving existing methodologies and enhancing the efficiency of pharmaceutical production.

Latest Patents

Anil Shamraj Bhoyar holds a patent for a process related to the preparation of remimazolam. This invention pertains to an improved method for synthesizing a compound of formula V or its salts. The patent also outlines a process for preparing a compound of formula I, which is essential in the synthesis of the compound of formula V. This innovative approach showcases his expertise in chemical processes and his dedication to advancing pharmaceutical science.

Career Highlights

Anil Shamraj Bhoyar is currently employed at Fresenius Kabi Oncology Limited, where he applies his knowledge and skills to develop cutting-edge pharmaceutical solutions. His role at the company allows him to contribute to the advancement of oncology treatments, making a positive impact on patient care.

Conclusion

Anil Shamraj Bhoyar is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patent for the preparation of remimazolam exemplifies his commitment to improving drug synthesis processes. Through his career at Fresenius Kabi Oncology Limited, he continues to make significant contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…